AllianceBernstein
MDT icon

AllianceBernstein’s Medtronic MDT Stock Holding History

AllianceBernstein’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-50,000
Closed -$3.56M – 3016
2016
Q4 		$3.56M Buy
+50,000
New +$3.93M ﹤0.01% 1411

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AllianceBernstein's MDT Position: Q2 2026 in Review

AllianceBernstein reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $96.7M and leaving 6,621,751 shares worth $574M. The position accounts for 0.19% of the portfolio, ranked #104.

AllianceBernstein first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.17B in Q2 2021. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • AllianceBernstein held 6,621,751 shares of Medtronic worth $574M as of Q2 2026.
  • AllianceBernstein sold 1,199,318 Medtronic shares in Q2 2026, an estimated $96.7M.
  • Medtronic made up 0.19% of AllianceBernstein's portfolio in Q2 2026, its #104 holding.
  • AllianceBernstein first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • AllianceBernstein's Medtronic position peaked at $1.17B in Q2 2021.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.